Skip to main content

Midazolam (International)

Note: In some countries, this medicine may only be approved for veterinary use.

In the US, Midazolam (midazolam systemic) is a member of the drug class benzodiazepines and is used to treat ICU Agitation, Light Anesthesia, Light Sedation, Seizures and Status Epilepticus.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N05CD08

CAS registry number (Chemical Abstracts Service)

0059467-70-8

Chemical Formula

C18-H13-Cl-F-N3

Molecular Weight

326

Therapeutic Categories

Hypnotic agent

Benzodiazepine derivative

Agent for premedication

Agent for procedural sedation

Anesthetic, injectable

Chemical Name

4H-Imidazo[1,5-a][1,4]benzodiazepine, 8-chloro-6-(2-fluorophenyl)-1-metyl-

Foreign Names

Generic Names

Brand Names

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.